Caldwell J L, Kaltreider H B
Exp Lung Res. 1980 Jun;1(2):99-110. doi: 10.3109/01902148009069640.
In order to demonstrate whether specific cytotoxic T cells could be induced in lung parenchyma, C57BL/6 mice were immunized by the intrapulmonary route with allogenetic tumor cells (P815). Ten days after administration of 20 x 10(6) allogeneic cells, peak concentrations of cytotoxic cells were found in lung, tracheobronchial lymph node, and spleen. With reduction in immunizing dose, lytic activity disappeared from spleen and lymph node, but persisted in lung. The cytolytic activity was specific for the immunizing alloantigen, was abolished by antitheta serum, and could not be attributed to macrophages. For comparison, C57BL/6 mice were immunized by the intraperitoneal route with 20 x 10(6) P815 cells. The expected cytolytic activity was found in spleen and lymph nodes: however, unexpectedly high levels of cytolytic activity were also found in pulmonary lymphocytes. This activity was confirmed using a wide range of effector to largest cell ratios in the assay system. Quantitative cytolytic assays demonstrated that the maximum rate of cytolysis by pulmonary lymphocytes obtained from mice immunized intraperitoneally exceeded by 10- to 20-fold the rate of cytolysis by pulmonary lymphocytes obtained from mice receiving intrapulmonary immunization. These data demonstrate that cytolytic T-lymphocytes appear in lung parenchyma after either intrapulmonary or intraperitoneal immunization and that the intraperitoneal route is far more efficient than the intrapulmonary route. This cell-mediated immune mechanism potentially is available for host defense of respiratory tissue.
为了证明肺实质中是否能诱导出特异性细胞毒性T细胞,将C57BL/6小鼠经肺内途径用同种异体肿瘤细胞(P815)免疫。给予20×10⁶个同种异体细胞10天后,在肺、气管支气管淋巴结和脾脏中发现细胞毒性细胞的峰值浓度。随着免疫剂量的降低,脾脏和淋巴结中的溶解活性消失,但在肺中持续存在。细胞溶解活性对免疫同种异体抗原有特异性,被抗θ血清消除,且不能归因于巨噬细胞。作为对照,将C57BL/6小鼠经腹腔途径用20×10⁶个P815细胞免疫。在脾脏和淋巴结中发现了预期的细胞溶解活性;然而,在肺淋巴细胞中也意外地发现了高水平的细胞溶解活性。在检测系统中使用广泛的效应细胞与靶细胞比例证实了这种活性。定量细胞溶解试验表明,经腹腔免疫的小鼠肺淋巴细胞的最大细胞溶解率比经肺内免疫的小鼠肺淋巴细胞的细胞溶解率高10至20倍。这些数据表明,经肺内或腹腔免疫后,细胞毒性T淋巴细胞出现在肺实质中,并且腹腔途径比肺内途径效率高得多。这种细胞介导的免疫机制可能可用于呼吸道组织的宿主防御。